Apr 24 2026 This Week in Cardiology copertina

Apr 24 2026 This Week in Cardiology

Apr 24 2026 This Week in Cardiology

Ascolta gratuitamente

Vedi i dettagli del titolo

A proposito di questo titolo

PCSK9 inhibitors in high-risk diabetes without ASCVD, the CAAN-AF trial, conduction system pacing vs biventricular pacing, PFA and stroke, and therapeutic fashion infects expert consensus are the topics John Mandrola, MD, discusses in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I VESALIUS-CV

  • VESALIUS-CV Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2514428
  • JAMA Substudy https://jamanetwork.com/journals/jama/fullarticle/2847162

II How Best to Maximize CRT Benefit in Patients with AF

  • CAAN-AF Trial https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag206/8654625?searchresult=1
  • Role of AV Node Ablation: Meta-analysis of Observational Studies https://www.jacc.org/doi/10.1016/j.jacc.2011.10.891

III Stroke Rates in PFA vs Thermal Ablation

  • Comparative Safety of RF versus PFA for AF in a High-Volume US Medical Center https://esc365.escardio.org/Ehra-congress/sessions/18281

IV Five New CSP Studies Presented and Published

  • HeartSync-LBBP Trial https://jamanetwork.com/journals/jamacardiology/fullarticle/2845803
  • PhysioSync-HF Trial

https://jamanetwork.com/journals/jamacardiology/fullarticle/2845802

  • LEFT-BUNDLE-CRT Trial https://doi.org/10.1093/eurheartj/ehag225
  • Long-Term Follow-up of His-Alternative I Trial https://www.jacc.org/doi/10.1016/j.jacep.2026.02.016
  • LECART Trial https://esc365.escardio.org/Ehra-congress/sessions/17140

V New EP Training Document Published

  • Advanced Training Statement on Clinical Cardiac Electrophysiology https://www.jacc.org/doi/10.1016/j.jacc.2026.01.074

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

Ancora nessuna recensione